Gold nanoparticle-based colorimetric assay for cancer diagnosis

Jeong Hun Kang, Yoji Asami, Masaharu Murata, Hirotaro Kitazaki, Noriaki Sadanaga, Eriko Tokunaga, Satoko Shiotani, Satoko Okada, Yoshihiko Maehara, Takuro Niidome, Makoto Hashizume, Takeshi Mori, Yoshiki Katayama

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

A novel gold nanoparticle (GNP)-based colorimetric assay was developed for cancer diagnosis. This system is based on the noncrosslinking aggregation mechanism with a cationic protein kinase C (PKC) α-specific peptide substrate, which is used as a coagulant of citrate-coated GNP with anionic surface charges. The phosphorylation of peptide substrates by PKCα suppressed GNP aggregation, resulting in a red color, but in the case of non-phosphorylation, the color of the GNP solution changed from red to blue, indicating particle aggregation. Moreover, a correlation between the color change of the GNP dispersions and the level of activated PKCα was identified from experiments using cancer cell lines, or xenografted mouse cancer and normal mouse tissues. When our system was applied to human breast cancers and normal human breast tissues, cancer tissue lysates became red in color, indicating GNP dispersion, while all lysates from normal tissue turned the GNP solution blue. MALDI-TOF MS analysis and Western blotting experiment confirmed that these different results between cancer and normal tissues reflected the difference in PKCα activity. This study is the first report on the application of the GNP-based colorimetric assay to the diagnosis of cancer.

Original languageEnglish
Pages (from-to)1869-1874
Number of pages6
JournalBiosensors and Bioelectronics
Volume25
Issue number8
DOIs
Publication statusPublished - Apr 15 2010

Fingerprint

Gold
Nanoparticles
Assays
Protein Kinase C
Tissue
Neoplasms
Color
Proteins
Agglomeration
Peptides
Breast Neoplasms
Coagulants
Phosphorylation
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Substrates
Surface charge
Dispersions
Citric Acid
Western Blotting
Experiments

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Biophysics
  • Biomedical Engineering
  • Electrochemistry

Cite this

Kang, J. H., Asami, Y., Murata, M., Kitazaki, H., Sadanaga, N., Tokunaga, E., ... Katayama, Y. (2010). Gold nanoparticle-based colorimetric assay for cancer diagnosis. Biosensors and Bioelectronics, 25(8), 1869-1874. https://doi.org/10.1016/j.bios.2009.12.022

Gold nanoparticle-based colorimetric assay for cancer diagnosis. / Kang, Jeong Hun; Asami, Yoji; Murata, Masaharu; Kitazaki, Hirotaro; Sadanaga, Noriaki; Tokunaga, Eriko; Shiotani, Satoko; Okada, Satoko; Maehara, Yoshihiko; Niidome, Takuro; Hashizume, Makoto; Mori, Takeshi; Katayama, Yoshiki.

In: Biosensors and Bioelectronics, Vol. 25, No. 8, 15.04.2010, p. 1869-1874.

Research output: Contribution to journalArticle

Kang, JH, Asami, Y, Murata, M, Kitazaki, H, Sadanaga, N, Tokunaga, E, Shiotani, S, Okada, S, Maehara, Y, Niidome, T, Hashizume, M, Mori, T & Katayama, Y 2010, 'Gold nanoparticle-based colorimetric assay for cancer diagnosis', Biosensors and Bioelectronics, vol. 25, no. 8, pp. 1869-1874. https://doi.org/10.1016/j.bios.2009.12.022
Kang JH, Asami Y, Murata M, Kitazaki H, Sadanaga N, Tokunaga E et al. Gold nanoparticle-based colorimetric assay for cancer diagnosis. Biosensors and Bioelectronics. 2010 Apr 15;25(8):1869-1874. https://doi.org/10.1016/j.bios.2009.12.022
Kang, Jeong Hun ; Asami, Yoji ; Murata, Masaharu ; Kitazaki, Hirotaro ; Sadanaga, Noriaki ; Tokunaga, Eriko ; Shiotani, Satoko ; Okada, Satoko ; Maehara, Yoshihiko ; Niidome, Takuro ; Hashizume, Makoto ; Mori, Takeshi ; Katayama, Yoshiki. / Gold nanoparticle-based colorimetric assay for cancer diagnosis. In: Biosensors and Bioelectronics. 2010 ; Vol. 25, No. 8. pp. 1869-1874.
@article{cf8dc7449c1d43faae10ba049934a127,
title = "Gold nanoparticle-based colorimetric assay for cancer diagnosis",
abstract = "A novel gold nanoparticle (GNP)-based colorimetric assay was developed for cancer diagnosis. This system is based on the noncrosslinking aggregation mechanism with a cationic protein kinase C (PKC) α-specific peptide substrate, which is used as a coagulant of citrate-coated GNP with anionic surface charges. The phosphorylation of peptide substrates by PKCα suppressed GNP aggregation, resulting in a red color, but in the case of non-phosphorylation, the color of the GNP solution changed from red to blue, indicating particle aggregation. Moreover, a correlation between the color change of the GNP dispersions and the level of activated PKCα was identified from experiments using cancer cell lines, or xenografted mouse cancer and normal mouse tissues. When our system was applied to human breast cancers and normal human breast tissues, cancer tissue lysates became red in color, indicating GNP dispersion, while all lysates from normal tissue turned the GNP solution blue. MALDI-TOF MS analysis and Western blotting experiment confirmed that these different results between cancer and normal tissues reflected the difference in PKCα activity. This study is the first report on the application of the GNP-based colorimetric assay to the diagnosis of cancer.",
author = "Kang, {Jeong Hun} and Yoji Asami and Masaharu Murata and Hirotaro Kitazaki and Noriaki Sadanaga and Eriko Tokunaga and Satoko Shiotani and Satoko Okada and Yoshihiko Maehara and Takuro Niidome and Makoto Hashizume and Takeshi Mori and Yoshiki Katayama",
year = "2010",
month = "4",
day = "15",
doi = "10.1016/j.bios.2009.12.022",
language = "English",
volume = "25",
pages = "1869--1874",
journal = "Biosensors",
issn = "0956-5663",
publisher = "Multidisciplinary Digital Publishing Institute",
number = "8",

}

TY - JOUR

T1 - Gold nanoparticle-based colorimetric assay for cancer diagnosis

AU - Kang, Jeong Hun

AU - Asami, Yoji

AU - Murata, Masaharu

AU - Kitazaki, Hirotaro

AU - Sadanaga, Noriaki

AU - Tokunaga, Eriko

AU - Shiotani, Satoko

AU - Okada, Satoko

AU - Maehara, Yoshihiko

AU - Niidome, Takuro

AU - Hashizume, Makoto

AU - Mori, Takeshi

AU - Katayama, Yoshiki

PY - 2010/4/15

Y1 - 2010/4/15

N2 - A novel gold nanoparticle (GNP)-based colorimetric assay was developed for cancer diagnosis. This system is based on the noncrosslinking aggregation mechanism with a cationic protein kinase C (PKC) α-specific peptide substrate, which is used as a coagulant of citrate-coated GNP with anionic surface charges. The phosphorylation of peptide substrates by PKCα suppressed GNP aggregation, resulting in a red color, but in the case of non-phosphorylation, the color of the GNP solution changed from red to blue, indicating particle aggregation. Moreover, a correlation between the color change of the GNP dispersions and the level of activated PKCα was identified from experiments using cancer cell lines, or xenografted mouse cancer and normal mouse tissues. When our system was applied to human breast cancers and normal human breast tissues, cancer tissue lysates became red in color, indicating GNP dispersion, while all lysates from normal tissue turned the GNP solution blue. MALDI-TOF MS analysis and Western blotting experiment confirmed that these different results between cancer and normal tissues reflected the difference in PKCα activity. This study is the first report on the application of the GNP-based colorimetric assay to the diagnosis of cancer.

AB - A novel gold nanoparticle (GNP)-based colorimetric assay was developed for cancer diagnosis. This system is based on the noncrosslinking aggregation mechanism with a cationic protein kinase C (PKC) α-specific peptide substrate, which is used as a coagulant of citrate-coated GNP with anionic surface charges. The phosphorylation of peptide substrates by PKCα suppressed GNP aggregation, resulting in a red color, but in the case of non-phosphorylation, the color of the GNP solution changed from red to blue, indicating particle aggregation. Moreover, a correlation between the color change of the GNP dispersions and the level of activated PKCα was identified from experiments using cancer cell lines, or xenografted mouse cancer and normal mouse tissues. When our system was applied to human breast cancers and normal human breast tissues, cancer tissue lysates became red in color, indicating GNP dispersion, while all lysates from normal tissue turned the GNP solution blue. MALDI-TOF MS analysis and Western blotting experiment confirmed that these different results between cancer and normal tissues reflected the difference in PKCα activity. This study is the first report on the application of the GNP-based colorimetric assay to the diagnosis of cancer.

UR - http://www.scopus.com/inward/record.url?scp=77649180327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649180327&partnerID=8YFLogxK

U2 - 10.1016/j.bios.2009.12.022

DO - 10.1016/j.bios.2009.12.022

M3 - Article

VL - 25

SP - 1869

EP - 1874

JO - Biosensors

JF - Biosensors

SN - 0956-5663

IS - 8

ER -